Davide Cao
@CaoDavide
Followers
383
Following
844
Media
26
Statuses
98
Interventional Cardiologist and Researcher | Humanitas University 🇮🇹 Icahn School of Medicine at Mount Sinai 🇺🇸 Institut Cardiovasculaire Paris Sud 🇫🇷
Milano, Lombardia
Joined August 2019
🇪🇺 Prospective study evaluating Uninterrupted DOAC in planned transradial procedures 🩸2% BARC type 2, 3, or 5 at 30 days meeting OPC https://t.co/ff15SipwvU
@ChiaritoMauro @ignamatsant @JuradoRomanAl @CaoDavide @beavaquerizo @GGStefanini @JaSorolla @JL_10_HILL @hect2701
onlinelibrary.wiley.com
Background Patients receiving direct oral anticoagulation (DOAC) often require coronary angiography with or without percutaneous coronary intervention (PCI). Guidelines recommend DOAC withdrawal...
2
7
22
Clinical case competition at #jimgise2025: inspiring management and discussion of complex cases! @jimcongress @TCTConference collaboration🫀
0
4
14
What a great first-time experience at #LondonValves 2024! Big shoutout to #PCR for the fantastic program and organization (I forgive you for uploading my slides to the wrong session). Definitely becoming a regular attendee of this course. #PCRLV @PCRonline
1
1
6
Kicked off #TCT with an incredible first LBT session, diving into the latest data on early intervention for aortic stenosis. @TCTConference @TCTMD @crfheart
0
3
7
Don’t miss tomorrow’s #CardioStories with Prof. @EmanueleBarba13 on the pitfalls and biases of RCTs. #webinar 🗓️ 4th September at 17:00 CEST 👉 Free registration — link in the comments
Randomized trials are the gold standard in clinical research, providing the strongest evidence for treatment effectiveness. However, they come with their own challenges and limitations Join @EmanueleBarba13 & me on Sept 4th as we discuss pitfalls and biases of RCTs 👉Link below
1
1
7
How do you manage slow flow/ o reflow and large thrombus burden? A great case-based and evidence-laden talk by @CaoDavide
#ESCCongress
1
2
2
Randomized trials are the gold standard in clinical research, providing the strongest evidence for treatment effectiveness. However, they come with their own challenges and limitations Join @EmanueleBarba13 & me on Sept 4th as we discuss pitfalls and biases of RCTs 👉Link below
1
1
5
ACS presentations often limit the use of short DAPT after PCI, even among HBR patients. Our new study shows 1-month DAPT after NSTE-ACS is safe and reduces bleeding—though there are some caveats! 👉 Learn more in @EuroInterventio
https://t.co/VY8sdexo9n
1
8
38
🔥 CALIPSO trial 🔥 Showing larger MSA (1.0 mm2 ⬆️) and less ⬇️ stent malapposition in OCT 📸 vs Angie guided PCI 🫀#EuroPCR2024 @PCRonline @nicolasamabile
0
10
30
#EuroPCR - Behind the scenes! 🎥 Live case from @ICPS on LM & complex bifurcation PCI with @DrThomasHovasse & @HakimBenamer H 13:30 Theatre Bleu See you soon
1
6
19
game, set, match for ICs 🤝
#ACC24 Round Up: Ten Original Articles were simultaneously published in NEJM and presented at this year’s American College of Cardiology Scientific Sessions in Atlanta. View the full thread for all @ACCinTouch articles and bookmark this post for future reference.
0
1
10
How to read (and do) a systematic review and meta-analysis? Learn more with our guest expert @DFCapodanno. 🗓️ 15th April at 17:00 CEST 👉 Free registration — link in the comments Don't miss out! #CardioStories
3
13
59
In 2018 during @jimcongress, my first “job interview” for a research scholarship at @MountSinaiHeart with @Drroxmehran. Now returning six years later to join an esteemed faculty with exciting live cases and educational sessions! #JIMcongress2024
0
1
21
And now stay tuned for the CALIPSO and DOCTORS LM results at #EuroPCR 2024 - LBT session on intracoronary imaging! 🔥
1
2
1
Besides increased costs and procedural time, routine use of intravascular imaging is probably unnecessary (as recent evidence suggests), but for complex cases or when the strategy is uncertain it really adds precision to PCI.
1
0
0